Search results
- Alkaptonuria: Current Perspectives / Zatkova A., Ranganath L., Kadasi L. . The application of clinical genetics . - 2020 Jan 23;13:37-47 [Dokument nie je vo fonde knižnice]
article
- Alkaptonúria: vzťah genotyp - fenotyp, klinický obraz a diagnostika ochorenia / Richard Imrich ... [et al.] . Interná medicína : recenzovaný, postgraduálne zameraný odborný lekársky časopis. - ISSN 1335-8359 . - Roč. 21, č. 9 (2021), s. 393-397 : ilustr., aj fareb., obr.
- C 3021
article
- Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria / Ranganath, L. R. ... [et al.] . Scientific Reports . - Vol. 12 (2022b) 16083 [Dokument nie je vo fonde knižnice]
article
- Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial / Ranganath, L. R. ... [et al.] . The lancet. Diabetes & endocrinology . - Vol. 8, č. 9 (2020), s. 762-772 [Dokument nie je vo fonde knižnice]
article
- Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria / Ranganath, L. R. ... [et al.] . Journal of inherited metabolic disease . - Vol. 43, no. 4 (2020a), s. 737-747 [Dokument nie je vo fonde knižnice]
article
- Suitability of nitisinone in alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment / Ranganath, L. R. ... [et al.] . Annals of the rheumatic diseases . - Vol. 75 (2016), s. 362-367 [Dokument nie je vo fonde knižnice]
article
- Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuria / Ranganath, L. R. ... [et al.] . Molecular genetics and metabolism . - S1096-7192(22)00325-0, (2022a) [Dokument nie je vo fonde knižnice]
article